ReviewFrontiers in cellular and infection microbiology2024

Progress in the study of mefloquine as an antibiotic adjuvant for combination bacterial inhibition treatment.

Xiaofang Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.